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Malaria is now known to affect over 500 million persons worldwide, killing about 1 to 3 million 
of them annually. Plasmodium falciparum is the species mostly implicated in the causation of 
severe malaria. This study was carried out to investigate the kidney function status of malaria 
patients in Benin metropolis, Southern Nigeria, to ascertain if there is renal 
dysfunction/impairment in them. Plasma levels of sodium, potassium, bicarbonate, urea, 
creatinine and blood urea nitrogen (BUN) were assayed in a total of 152 subjects (112 malaria 
patients infected with Plasmodium falciparum and 40 controls) of both sexes, with their age 
ranging from 8 to 42 years. The results observed irrespective of age or sex, reveal a 
statistically significant (p<0.05) increase in plasma levels of potassium, urea, BUN and 
creatinine (4.49±0.95 mmol/L;5.88±0.13mmol/L;16.39±0.36mg/dl and 135.05±2.69µmol/L) when 
compared to their controls (4.05±0.34mmol/L;3.73±0.12mmol/L;10.34±0.36mg/dl and 





 (128.50±0.77 and 19.98±0.28mmol/L) when compared to their controls 
(l38.58±0.29 and 24.70±0.36mmol/L, respectively). The hyponatraemia and metabolic acidosis 
observed in the malaria patients are negatively correlated with the degree of parasitaemia (r=-
0.241 and r=-0.019, respectively), while the elevated plasma potassium and creatinine levels 
are positively correlated with the degree of parasitaemia (r=0.153 and r=0.407, respectively). 
The elevated plasma Urea and BUN levels are also positively correlated with the degree of 
parasitaemia (r=0.371 and r=0.375, respectively). The results of this study indicate that there is 
significant renal dysfunction/impairment in patients in southern Nigeria infected with 
plasmodium falciparum. 
 





Malaria is a life-threatening, mosquito-borne, 
parasitic, infectious disease caused by a 
eukaryotic protist of the genus Plasmodium, 
transmitted through the bite or the female 
anopheles mosquito (WHO, 2009). Five 
species of the plasmodium parasite can infect 
humans; the most serious forms of the disease 
are caused by Plasmodium falciparum (WHO, 
2009). Each year, there are pproximately 350-
500 million cases of malaria, killing between 
one and three million people, the majority of 
whom are young children in sub-Saharan 
Africa (Snow et al., 2005). Ninety percent of 
malaria-related deaths occur in sub-Saharan 
Africa. Malaria is commonly associated with 
poverty, and can indeed be a cause of poverty 
and a major hindrance to economic 
development (Snow et al., 2005; Sachs et al., 
2002).  
The pathophysiology of severe 
Plasmodium falciparum is characterized by 
anaemia, jaundice, liver failure, acute renal 
failure and sometimes death (Beare, et al., 
2006). A common pathological change also 
observed in human and animal malaria is fatty 
infiltration in liver parenchyma cells which 
causes changes in the way the liver 
metabolizes certain metabolites (Fletcher and 
Maegraith, 1966). Severe organ damage has 
been reported in chronic cases and organs 
commonly affected include the gastro-
intestinal tract, brain, liver, and the kidneys 
(Wernsdorfer and McGregor, 1988). 
 Research over the years has shown 
that the possible pathogenetic mechanisms 
are hyperparasitaemia with sequestration in 
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internal organs, intravascular haemolysis, 
Disseminated Intravascular Coagulopathy and 
immune and cytokine mediated injury 
(Bhattacharya and Manesh, 1998; Garg, 
2000). Several factors including various 
chemical mediators, catecholamine release, 
cytoadherence of parasitized erythrocytes, 
dehydration, intravascular haemolysis, 
intravascular coagulation, sepsis, 
hyperbilirubinaemia and hyperparasitaemia, 
have been implicated in the pathogenesis of 
Acute Renal Failure (ARF) in malaria (Eiam-
Ong and Sitprija, 1998; Mishra and Das, 
2008). Acute tubular necrosis is the principal 
pathologic mechanism in malaria induced ARF 
(Eiam-Ong and Sitprija, 1998). 
Recently, there is a changing trend not 
only in the clinical manifestations but also the 
pattern of complications in malaria. Over a 
decade ago, cerebral malaria was the 
predominant manifestation of severe malaria, 
whereas today the combination of jaundice 
and renal failure are more common (Nand et 
al., 2001). The hepatic and renal 
manifestations have been frequent and their 
mode of presentation has undergone a change 
making it difficult for the treating physician to 
differentiate these from other ailments. The 
renal involvement in malaria varies widely, 
from asymptomatic proteinuria to acute renal 
failure (ARF) (Boonpucknavig and Sitprija, 
1979; Nand, et al., 1997). Reversible nephrotic 
syndrome is specifically associated with P. 
malariae infection (Claire et al., 2004).  
Prevalence of Acute Renal Failure 
(ARF) in malaria all over the world has been 
reported as 0.57% to 60% (Mehta et al., 
2001). In Southeast Asia there is an upsurge 
in the overall incidence of malarial ARF and 
has been reported to be between 13% and 
17.8% (Mehta et al., 2001). ARF occurs 
commonly in Plasmodium falciparum malaria, 
although its rare occurrence has been 
reported in plasmodium vivax malaria 
(Parkash et al., 2003). The disease is more 
common in adults in those areas of the tropics 
where transmission of malaria is low or 
unstable and where symptomatic disease 
occurs at all ages (WHO, 2000). Established 
ARF is usually oliguric, but urine output may 
also be normal or even increased in the 
presence of increasing serum creatinine 
values (WHO, 2000). 
Depending on the degree of 
parasitaemia, the effect of Plasmodium 
falciparum on the kidneys and other organs is 
normally expressed in derangement in plasma 
electrolytes like a significant decrease in 
plasma sodium and elevation in plasma 
potassium (Alumanah et al., 1994) and many 
other metabolites which may be as a result of 
a dysfunction in the kidneys or liver (Onyeneke 
et al., 2003). These changes in many 
metabolites and the overall metabolism of the 
system(s) affected can sometimes result in 
death (Kreier, 1980; Ononogbu and 
Onyeneke, 1983; Alumanah et al., 1994). 
In the last few years there has been a 
mass resurgence in malaria (Nand et al., 
2001). Despite efforts to reduce transmission 
and increase treatment, there has been little 
change in areas which are at risk of this 
disease since 1992 (Hay et al., 2004). Indeed, 
if the prevalence of malaria stays on its 
present upwards course, the death rate could 
double in the next twenty years (Breman, 
2001). Precise statistics are unknown because 
many cases occur in rural areas where people 
do not have access to hospitals or the means 
to afford health care. As a consequence, the 
majority of cases are undocumented (Breman, 
2001). 
Considering the endemicity of malaria 
in Nigeria and the mortality rate across 
families, accurate prognosis and proper 
management are very necessary. The 
incidence of kidney problems is on the 
increase in Nigeria, malaria and other 
infectious diseases may be contributing factors 
(Ogbadoyi and Gabi, 2007; Ekeanyanwu and 
Akpoilih, 2010). It is therefore important to 
know the prevalence level of renal involvement 
in malaria cases to ensure effective 
management of patients as they report to 
medical centres (Ogbadoyi and Gabi, 2007; 
Ekeanyanwu and Akpoilih, 2010). This is 
important because in the presence of acute 
renal failure, death increases three fold but 
with early detection and institution of frequent 
dialysis, mortality rate is reduced by 90% 
(Mishra et al., 2007).  
Research regarding the effect of 
malaria on the kidneys, done in other parts of 
the world has been associated commonly with 
children under five years of age. So the 
impression in Southern Nigeria among adults 
more often than not is that kidney failure from 
malaria is a disease of Caucasians and 
„under-five‟ children in Nigeria. Not much has 
been done comprehensively and in one single 
research in South-South Nigeria to understand 
the pathophysiology of malaria with respect to 
the kidneys.    
The aim of this research is to 
determine the kidney function status of malaria 
patients in Benin metropolis, Southern Nigeria, 
It is the hope that any changes observed will 
not just aid the understanding of malaria 
pathogenesis in our environment but it will be 
applied to improve malaria diagnosis and 
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management as this will also bring to the 
consciousness of attending physicians, the 
need to not just prescribe appropriate doses of 
antimalarial drugs, but carry out routine renal 
function tests especially for those patients with 
severe infection and slow rate of recovery, 
with the intention of possible correction of any 
anomaly, especially those persisting after 
several days of treatment. 
   
Materials and Methods 
 
Study subjects: The study subjects were 
made up of a total of one hundred and forty 
(140) patients who reported ill with signs and 
symptoms suggestive of malaria and had not 
been placed on any anti-malaria drug. One 
hundred and twelve (112) of them (both sexes) 
were confirmed to have Plasmodium 
falciparum malaria and expressed symptoms 
ranging from fever (axillary temperature 
>37.5
o
C), body/joint pain and headache to 
other clinical signs and symptoms of malaria 
as previously documented. The subjects who 
did not meet these criteria were excluded from 
the study. They were recruited from the 
General Out-Patient Departments of: the 
University of Benin Teaching Hospital, the 
University of Benin Health Centre, Ugbowo 
Campus, St. Philomena‟s Catholic Hospital, 
Dawson Road and Save Heavens Clinic all in 
the Benin Metropolis and transversing Oredo 
and Egor Local Government Areas of Edo 
State, South-South of Nigeria. The subjects 
were all Nigerians, resident in and around 
Benin City. They were divided into four 
different age ranges; 5-15. 16-25, 26-35, 36-
45years. 
Forty (40) apparently healthy age-
matched individuals, who also did not test 
positive as carrying the malaria parasite were 
used as controls; though fifty (50) subjects 
were initially tested, only forty (40) of them 
were found suitable for use as controls. 
Informed consent was obtained from all the 
subjects and adequate approval was given by 
the personnel in charge in the health 
institutions before the study commenced. 
 
Inclusion criteria: All the test subjects were 
confirmed to be infested with the malaria 
parasite. All control subjects were apparently 
healthy and had levels of the parameters 
being investigated within the normal range 
acceptable for Nigerians.  
 
Exclusion criteria: Test subjects that did not 
test positive as carriers of the malaria parasite 
(even if this does not mean they did not have 
malaria) and control subjects that either tested 
positive as carriers of the malaria parasite or 
expressed symptoms of other diseases or 
abnormal levels of the parameters being 
investigated were excluded from this study. 
 
Sample collection and preparation: two 
specimen bottles were used for each subject. 
Anticoagulant bottles containing dipotassium 
ethylenediaminetetraacetic acid (K2 EDTA) for 
malaria parasite test and lithium heparin 
bottles for assay of other parameters were 
used for initial collection of blood from all 
subjects. Blood samples (5ml) were collected 
by clean venipuncture from the ante-cubital 
fossa of the subjects into already labeled 
bottles without undue pressure to either the 
arm or the plunger of the syringe. The samples 
were mixed by gentle inversion. The samples 
in the K2 EDTA anticoagulant bottles were 
tested immediately for malaria parasite, after 
staining their thick films with Giemsa stain. 
Giemsa stained thin films confirmed the 
malaria parasite as purely Plasmodium 
falciparum, which is in keeping with the strain 
common in or endemic to Nigeria. The 
samples in the lithium heparin bottles were 
centrifuged at 4000r/min for 5mins to obtain 
plasma. The plasma were separated into 
sterile plain bottles and were used for assay of 
the required parameters; when immediate 
analysis was not possible, the samples were 
stored in the refrigerator (2–8
o
C) and analysis 
carried out within 4 days. 
 
Malaria parasite density determination: the 
malaria parasite density was determined by 
examining a thick blood film stained by 
Giemsa method (Cheesbrough, 1998).  
 
Classification of the degree of 
parasitaemia: The malaria parasite density 
was graded as follows:  
 1 parasite/field: low density/ mild 
parasitaemia (+)  
 2-9 parasites/field: medium 
density/moderate parasitaemia (++) 
 More than 20 parasites/field: high 
density/severe parasitaemia (+++) 
(Cheesbrough, 1998). 
 





): the plasma sodium and 
potassium levels were analyzed using flame 
emission spectrophotometric method (Flame 
Photometer) (Tietz et al., 1996).  
 
Determination of Plasma Bicarbonate 
(HCO3
-
):  This was estimated following the first 
principle method (Titrimetric method) 
described by Davidson and Henry (1979) 
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Determination of Plasma Urea and Blood 
Urea Nitrogen (BUN): a urea Kit from Randox 
Laboratories Limited, UK (purchased from 
manufacturer‟s representative in Nigeria) was 
used. The assay method used, was that of 
Berthelot (Weatherburn, 1967). The Blood 
Urea Nitrogen was then determined using the 
formula: 
BUN Concentration (mg/dl) = Urea Conc. 
(mmol/l) x 2.8 (Johnson et al., 1972).  
 
Determination of Plasma Creatinine: a 
creatinine Kit from Randox Laboratories 
Limited, UK (purchased from manufacturer‟s 
representative in Nigeria) was used. The 
assay method used, was that described by 
Bartels and Bohmer (1972). 
 
Statistical analysis: all the data from the 
study were statistically analyzed at 95% 
confidence interval. Some of the parameters 
were also investigated statistically for any 
correlation between them by determining their 
scatter plots and correlation coefficients. The 
analysis was done using the Statistics for 
Windows 16 version of Statistical Package for 
Social Sciences (SPSS - Windows 16). 
Results are presented as mean + standard 
error of mean (SEM) and p<0.05 are 




The Kidney function status of Nigerian Human 
Malaria patients from South-South Nigeria was 
investigated using some biochemical indices. 
                  Table 1 shows some biochemical 
indices of the malaria patients. The mean age 
of the subjects used for the study did not differ 
significantly (P>0.05) while the other 







Urea, BUN, and Creatinine) for malaria 
subjects differ significantly (P<0.05) when 
compared to controls indicating that P. 
falciparum infection expressed significant 





 (metabolic acidosis), 
and significant elevation in plasma levels of 
K
+
, Urea and BUN (azotaemia) and creatinine 
(hypercreatininaemia), in these patients.  
 





















 (mmol/L) 4.49+ 0.95
a





 (mmol/L) 19.98 + 0.28
a
 24.70 + 0.36
b
 
Urea (mmol/L) 5.88 + 0.13
a
 3.73 + 0.124
b
 
BUN (mg/dL) 16.39 + 0.36
a
 10.34 + 0.36
b
 
Creatinine (µmol/L) 135.05 + 2.69
a





Results obtained also indicate that 
irrespective of the age of the patients, malaria 
infection universally caused a significant 
reduction (P<0.05) in the plasma levels of Na
+
 
(hyponatraemia) and HCO3 (metabolic 
acidosis) and a significant elevation (P<0.05) 
in the plasma levels of K
+
, Urea and BUN and 
creatinine (Table 2). 
 
 

















Values in the same box with different alphabets superscripts differ significantly (P<0.05) 
Parameters Subject N 5-15 N 16-25 N 26-35 N 36-45 
Na+ (mmol/L) Malaria 4 127.00+ 1.41a 75 129.03 + 0.94a 26 128.12+ 1.77a 7 125.14 + 2.77a 
Control 7 138.57+ 0.84b 22 136.68+0.397b 8 138.50+0.71b 3 138.00 + 0.58b 
K+ (mmol/L) Malaria 4 4.78+0.68a 75 4.41+0.11a 26 4.58+0.21a 7 4.90+0.37a 




Malaria 4 22.50+2.10a 75 20.20+0.05a 26 18.94+0.55a 7 20.00+0.82a 
Control 7 23.14+0.40a 22 25.7+0.03b 8 26.38+0.57b 3 26.00+1.53b 
Urea (mmol/L) Malaria 4 6.80+0.30a 75 5.80+0.14a 26 6.05+0.38a 7 5.61+0.45a 
Control 7 3.18+0.14b 22 3.71+0.169b 8 3.83+0.15b 3 4.83+0.68a 
BUN 
(mg/dL) 
Malaria 4 18.61+0.96a 75 16.22+0.40a 26 16.73+0.99a 7 15.70+1.27a 
Control 7 8.52 + 0.41b 22 10.34 + 0.05b 8 10.73 + 0.42b 3 13.54 + 1.91a 
Creatinine 
(µmol/L) 
Malaria 4 148.00+12.43a 75 131.90+3.06a 26 141.76+667a 7 137.00+10.93a 
Control 7 83.09+2.72b 22 82.19+2.59b 8 72.68+2.22b 3 85.67+3.82b 
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Table 3: Comparison between biochemical parameters in the different age brackets of malaria subjects 
Values in the same box with different alphabets superscripts differ significantly (P<0.05) 
 
Table 4: Biochemical indices of malaria patients in relation to the degree of parasitaemia 
 
Parameters Subjects N (+) N (++) N (+++) 
Na+            N 
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17 
40 
4.77 + 0.29a 
4.05+ 0.03b 
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Values in the same box with different alphabets superscripts differ significantly (P<0.05) 
 
Parameters 5-15           vs      16-25 5-15            vs      26-35 5-15          vs          36-45 16-25         vs           26-35 16-25          vs      36-45 26-35          vs          36-45 
Na+            N 
(mmol/L)       
4                           75 
 
127.00+1.41a129.03+0.94a 
4                               26 
 
127.oo+1.41a   128.12+1.77a 
4                                 7 
 
127.00+1.41a   125.14+2.77a 
75                           26 
 
129.03+0.94a       128.12+1.77a 
75                            7 
 
129.03+0.94a   125.14+2.77a 
26                            7 
 
128.12+1.77a  125.14+2.77a 
K+         N 
(mmol/L) 
4                       75 
 
4.78+0.68a  4.41+ 0.11a 
4                                26 
 
4.78+ 0.68a  4.58+ 0.21a 
4                                  7 
 
4.78+ 0.68a  4.90+0.37a 
75                            26 
 
4.41+ 0.11a  4.58+ 0.21a 
75                              7 
 
4.41+ 0.11a  4.90+ 0.37a 
226                           7 
 
4.58+ 0.21a  4.90+ 0.37a 
HCO3
-    N 
(mmol/L) 
4                       75 
 
22.50+2.10a  20.20+ 0.05a 
4                                26 
 
22.50+ 2.10a  18.94+ 0.55a 
4                                  7 
 
22.50+ 2.10a  20.00+0.82a 
75                            26 
 
22.20+ 0.05a  18.94+ 0.55a 
75                              7 
 
20.20+ 0.05a  20.00+ 0.82a 
26                           7 
 
18.94+ 0.55a  20.00+ 0.82a 
Urea       N 
(mmol/L)      
4                       75 
 
6.80+0.30a  5.80+ 0.14a 
4                                26 
 
6.80+ 0.30a  6.05+ 0.38a 
4                                  7 
 
6.80+ 0.30a  5.61+0.45a 
75                            26 
 
5.80+ 0.14a  6.05+ 0.38a 
75                              7 
 
5.80+ 0.14a  5.61+ 0.45a 
26                           7 
 
6.05+ 0.38a  5.61+ 0.45a 
BUN       N 
(mg/dL) 
4                       75 
 
18.61+0.96a  16.22+ 0.40a 
4                                26 
 
18.61+ 0.96a  16.73+ 0.99a 
4                                  7 
 
18.61+ 0.96a  15.70+1.27a 
75                            26 
 
16.22+ 0.40a  16.73+ 0.99a 
75                              7 
 
16.22+ 0.40a  15.70+ 1.27a 
26                           7 
 
16.73+ 0.99a  15.70+ 1.27a 
Creatinine N 
 (umol/L) 
4                       75 
 
148.0+12.43a131.90+ 3.06a 
4                                26 
 
148.0+ 12.43a  141.76+ 6.67a 
4                                  7 
 
148.0+12.43a 137.0+10.9a 
75                            26 
 
131.90+ 3.06a  141.76+ 6.67a 
75                              7 
 
131.90+ 3.06a  137.0+ 10.9a 
26                           7 
 
141.76+ 6.67a  137.0+10.93a 
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Table 3 represents the comparison 
between biochemical parameters in the 
different age brackets of malaria patients. 
Generally there was no significant (P>0.05) 
mean difference in the parameters assayed in 
the malaria patients in the respective age 
groups when the values assayed for the 
respective age groups were compared with 
each other. Table 4 shows the biochemical 
indices of malaria patients in relation to the 
degree of parasitaemia. Results obtained 
indicate that irrespective of the degree of 
parasitaemia, malaria infection universally 
caused a significant reduction (P<0.05) in the 
levels of plasma Na
+
 (hyponatraemia) and 
HCO3
-
 (metabolic acidosis) and a significant 
elevation (P<0.05) in plasma levels of K
+
, urea 
and BUN and creatinine, in these patients; and 
when compared to the different degrees of 
parasitaemia it was observed that there is a 
significant mean difference (P<0.05) in the 
plasma levels of sodium, potassium, urea, 
BUN and creatinine in the different levels of 
parasitaemia (Table 5). Table 6 represents the 
biochemical indices of malaria patients in 
relation to their sex. Results obtained indicate 
that though the levels of variation in the 
parameters assayed are generally higher in 
the males than in females, irrespective of the 
sex of the malaria patients, they both exhibit 
similar changes (P<0.05), like elevated levels 
of plasma potassium, urea, creatinine, BUN 
and reduced levels of plasma sodium and 
bicarbonate when compared with their 
corresponding male or female controls. When 
comparison between the biochemical indices 
in relation to their sex and degree of 
parasitaemia is made, the levels of variation in 
the biochemical indices assayed follow a 
similar pattern in the sexes but are generally 
higher in the males with increasing 
parasitaemia leading to elevated plasma 
potassium, urea, creatinine and BUN levels 
and hyponatraemia and metabolic acidosis, 
when compared with their corresponding male 
or female controls (Table 7).
 
 
Table 5: Comparison of biochemical parameters between the different degrees of parasitaemia 
in malaria subjects 
Parameters +              VS        ++ +            VS        +++ ++           VS       +++ 
Na+               N 
(mmol/L)  Value 
70 
129.70 + 1.04a 
25 
128.36 + 1.23a 
70 
129.69 + 1.04a 
17 




123.82 + 1.67b 
K+                N 
(mmol/l)   Value 
70 
4.37 + 0.12a 
25 
4.66 + 0..19a 
70 
4.37 + 0.12a 
17 




4.77 + 0.29b 
HCO3
-         N 
(mmol/l)   value 
70 
20.00 + 0.32a 
25 
20.08 + 0..56a 
70 
20.00 + 0.32a 
17 




19.76 + 1.00a 
Urea           N 
(mmol/l)   Value 
70 
5.53 + 0.14a 
25 
6.08 + 0..31a 
70 
5.53 + 0.14a 
17 




7.00 + 0.39a 
BUN          N 
(mg/dL)    Value 
70 
15.46 + 0.38a 
25 
16.81 + 0..79a 
70 
15.46 + 0.38a 
17 




19.60 + 1.10b 
Creatinine   N 
(µmol/l)   Value 
70 
127.00 + 2.86a 
25 
140.00 + 4..87a 
70 
127.00 + 2.86a 
17 




159.00 + 8.85b 
Values in the same block with different alphabets superscripts differ significantly (P<0.05) 
Table 6: Biochemical indices of malaria patients in relation to their sex 
Parameters              Subjects N Male N Female 
Na+ (mmol/L)            Malaria 
                                  Control                                
32 
21
129.16 + 1.30a  
138.14 + 0.43b 
80 
19 
128.24 + 0.94a  
139.05 + 0.37b 
K+ (mmol/L)               Malaria 
                                    Control 
32 
21 
4.48 + 0.18a  
4.08 + 0.06b 
80 
19 
4.50 + 0.11a  
4.01 + 0.4b 
HCO3
-(mmol/L)          Malaria 
                                    Control 
32 
21 
20.50 + 0.46a  
24.95 + 0.51b 
80 
19 
19.77 + 0.34a  
24.42 + 0.49b 
Urea (mmol/L)            Malaria 
                                    Control 
32 
21 
5.96 + 0.25a  
3.71 + 0.13b 
80 
19 
5.84 + 0.16a  
3.75 + 0.22b 
BUN(mg/dL)              Malaria 
                                   Control 
32 
21 
16.69 + 0.71a  
10.38 + 0.36b 
80 
19 
16.27 + 0.42a  
10.29 + 0.67b 
Creatinine (µmol/L)   Malaria 
                                    Control 
32 
21 
137.16 + 5.45a  
79.8 + 2.69b 
80 
19 
134 + 3.10a  
81.71 + 2.01b 
Values in the same box with different alphabets superscripts differ significantly (P<0.05) 
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Table 7: Comparison of biochemical indices of malaria patients in relation to their sex and 
degree of parasitaemia 
Parameter Subject       Mild Parasitaemia Moderate Parasitaemia Severe Parasitaemia 
  N        Male N    Female N       Male N     Female N      Male N      Female 
Na+ (mmol/L) Malaria 
Control 
20       131.55+1.37a 
21       138.14+ 0.43b 
50   128.94+ 1.33a 
19   139.05+ 0.37b 
7     126.14+ 2.82a 
21   138.14+ 0.42b 
18   129.22+ 1.31a 
19   139.05+ 0.37b 
5        123.80+ 3.94a 
21     138.14+ 0.42b 
12  123.83+  1.85a 





20       4.42+0.22a 
21       4.08+ 0.06b 
50   4.35+ 0.14a 
19   4.01+ 0.04b 
7    4.31+ 0.35a 
21   4.08+ 0.06a 
18   4.79+ 0.22a 
19   4.01+ 0.04b 
5        4.98+ 0.56a 
21     4.08+ 0.06b 
12  4.68+  0.34a 






20        20.70+ 0.48a 
21       24.95+ 051b 
50   19.70+ 0.40b 
19   24.42+ 0.49a 
7    19.57+ 0.92a 
21  24.95+ 0.50b 
18  20.28+ 0.69a 
19   24.42+ 0.49b 
5      21.00+ 1.94a 
21     24.95+ 0.50a 
12  19.25+  1.18a 





20        5.44+ 0.23a 
21       3.17+ 0.13b 
50   5.57+ 0.171a 
19   3..75+ 0.22b 
7    6.16+ 0.31a 
21  3.71+ 0.13b 
18  6.05+ 0.42a 
19   3.75+ 0.22b 
5      7.76+ 0.95a 
21     3.71+ 0.13a 
12  6.68+  0.38a 





20        15.23+ 0.64a 
21       10.29+ 0.67b 
50   15.55+ 0.47a 
19   10.38+ 0.67b 
7    17.24+ 0.87a 
21  10.38+ 0.36b 
18  16.64+ 1.05a 
19   10.29+ 0.67b 
5      21.74+ 2.66a 
21     10.38+ 0.36b 
12  18.71+  1.06a 





20       126.69+ 4.45a 
21       79.81+ 2.69b 
50  127.83+ 3.60a 
19   81.71+ 2.01b 
7    136.80+ 5.14a 
21  79.81+ 2.69b 
18  141.78+ 6.51a 
19   81.71+ 2.01b 
5     180.75+ 20.47a 
21    81.71+ 2.01b 
12  150.56+  8.58a 
19   81.71+ 2.01b 
Values in the same box with different alphabets superscripts differ significantly (P<0.05) 
 
 
The hyponatraemia and metabolic 
acidosis (reduced plasma bicarbonate) 
observed in the malaria patients are negatively 
correlated with degree of parasitaemia (r=-
0.241 and r=-0.019, respectively; Figures 1and 
2, respectively). The elevated plasma 
potassium and plasma creatinine levels 
observed in the malaria patients, positively 
correlated with the degree of parasitaemia 
(r=0.153 and r=0.407, respectively; figures 3 
and 4, respectively). The elevated plasma 
Urea and BUN levels observed in the malaria 
patients are positively correlated with the 
degree of parasitaemia (r=0.371 and r=0.375, 




Renal failure or kidney failure (formerly called 
renal insufficiency or chronic renal 
insufficiency) describes a medical condition in 
which the kidneys fail to adequately filter 
toxins and waste products from the blood 
(Evans, 1978). Biochemically, renal failure is 
typically detected by an elevated creatinine 
level in the blood and a decrease in the 
glomerular filtration rate (Evans, 1978). 
Problems frequently encountered in kidney 
malfunction include abnormal fluid levels in the 
body, deranged acid levels, abnormal levels of 
potassium, calcium, phosphate, haematuria 
(Blood in the urine) and (in the longer term) 
anaemia (Evans, 1978).  
In this present study it was observed 
that there was a statistically significant 
(P<0.05) hyponatraemia in the malaria 
infected patients. The hyponatraemia was 
observed to be negatively correlated with the 
degree of parasitaemia and is experienced in 
the malaria patients irrespective of their age or 
sex. This result of significant hyponatraemia 
aligns with the results obtained earlier by 
Ikekpeazu et al., (2010), in South-East Nigeria. 
The result of this study also corroborates the 
earlier work by Van-Wolfswinkel et al. (2010), 
where a hyponatraemia in malaria patients 
which negatively correlated with the degree of 
parasitaemia was observed. The results of this 
study however differs from that of 
Ekeanyanwu and Akpoilih (2010) who earlier 
reported that hyponatraemia was not observed 
as there was no significant change in plasma 
Na
+
 levels in the Plasmodium infected subjects 
compared to the controls. This study partly 
agrees with that of Ogbadoyi and Gabi (2007) 
who had shown a mean significant difference 
(P<0.05) in plasma sodium levels of all female 
categories of malaria patients and controls, but 
no significant difference (P>0.05) was found 
between the levels in male malaria patients 
and individuals without malaria. 
Hyponatraemia (serum sodium< 
135mmol/L) has long been recognized as a 
complication of malaria (English et al., 1996). 
In human erythrocytes infected with the 
mature form of the malaria parasite, 
Plasmodium falciparum, the cytosolic (ICF) 
concentration of sodium ion was found to be 
increased (Mattys et al., 2008) while its 
concentration was said to decrease in the ECF 
(Rajapurkar, 1994; Kakkilaya, 2003; Mutuku et 
al., 2009). 
The pathophysiology of 
hyponatraemia in malaria remains unclear but 
several studies have suggested that increased 
secretion of vasopressin, either appropriately 
or inappropriately, plays an important role 
(Miller et al., 1967; Sowunmi et al., 2000; 
Hanson et al., 2009). Other suggested 
mechanisms are absolute sodium deficit due 
to cerebral salt wasting, excessive sweating or 
loss in the gastrointestinal or urinary tract 
(Sowunmi, 1996), and the secretion of 
vasopressin which can be either appropriate, 
in case of volume depletion (Hanson et al., 
2009), or inappropriate as in the syndrome of 
inappropriate antidiuretic hormone secretion 
(Sowunmi et al., 2000) or reset osmostat 
(Miller et al., 1967). There is, however, no 
consensus as to their relative contributions. 
869 
Kidney function status in Nigerian human malaria patients  
In this study it was observed that there 
was a significant (P<0.05) increase in plasma 
potassium in the malaria infected patients 
when compared to the control subjects. The 
elevated plasma potassium level observed in 
the malaria patients positively correlated with 
the degree of parasitaemia and is experienced 
irrespective of age or sex. This result is similar 
to that earlier observed by Nand, et al., (2001) 
on patients with P. falciparum infection, and 
also partly corroborates the findings of 
Ogbadoyi and Gabi (2007) where significantly 
(P<0.05) elevated plasma potassium levels 
were found in male children. The results 
however differs from that obtained by 
Wiwanitkit (2007) who documented no 
significant change (P>0.05) and correlation in 
serum potassium levels in patients with 
falciparum malaria and that obtained by 
Ikekpeazu et al., (2010), where a significant 
lowering of serum potassium was discovered 
in P. falciparum infected patients. 
Compartment analysis of infected cells 
revealed that the cytosol of the host cell is 
poor in potassium and rich in sodium and that 
this relationship is reversed in the parasite and 
the serum, indicating an ability for independent 
regulation of ionic composition by the parasite 
(Wiwanitkit, 2007; Matthys et al., 2008). White 
and Kilbey (1996) who reported that host cells 
lose up to 75-80% of their normal potassium 
content during the course of a malaria attack 
also gives credence to why an elevation of 
potassium in the serum or plasma is 
sometimes observed in malaria patients. 
Alappa et al. (1996) reported that potassium 
being solely excreted by the kidneys could 
become elevated in plasma if any dysfunction 
in the kidney is experienced as this would 
result in its reduced excretion, this may 
account for the elevated K
+
 levels in malaria 
subjects with kidney disease. The elevated 
plasma potassium levels found in this present 
study can be therefore be due to rapid 
haemolysis of malaria-infected red blood cells 
and the inability of the malaria-compromised 
kidneys to properly regulate and keep the 
serum potassium levels within healthy limits. 
Our study also observed that there 
was a significant (P<0.05) metabolic acidosis 
(decreased plasma bicarbonate-HCO3
-
) in the 
malaria infected patients. The metabolic 
acidosis observed in the malaria patients was 
found to be negatively correlated with the 
degree of parasitaemia. These findings are in 
agreement with the findings of the earlier study 
carried out by Nand et al. (2001) where renal 
dysfunction was found to be more in patients 
with falciparum malaria with heavy 
parasitaemia. They also found that these 
patients had a bicarbonate level <20mmol/L 
indicative of low bicarbonate with the patients 
expressing features of metabolic acidosis. The 
findings of this present study partly agrees 
with the earlier studies of Adeosun et al. 
(2007) on parasitaemic children from South 
Western Nigeria, where plasma bicarbonate 
levels in the parasitaemic children were 
significantly lower (P<0.05) than that in the 
non-parasitaemic controls but this elevation 
was not found to increase with increasing 
parasitaemia. Also, Ogbadoyi and Gabi (2007) 
have reported in Minna, Nigeria that metabolic 
acidosis was found only in children. 
The World Health Organisation (WHO) 
already recognizes a plasma bicarbonate 
concentration of less than 22mmol/L as 
metabolic acidosis, and recognizes it as one of 
the severe manifestation and complications of 
P. falciparum malaria (WHO, 2000). Metabolic 
acidosis has long been associated with 
Plasmodium falciparum malaria with renal 
involvement ranging from mild proteinuria to 
severe azotaemia. The metabolic acidosis 
seen in this present study may result from 
possible retention of acidic end products of 
metabolism, hyperventilation, and lactic 
acidosis from fever and rigors and associated 
increase catabolic activity following 
Plasmodium falciparum infection complicated 
by depressed renal function (Boonpucknavig 
and Sitprija, 1979; Mishra et al., 2007; Mishra 
and Das, 2008). Trampuz et al. (2003) in his 
clinical review has indicated that metabolic 
acidosis was one of the common systemic 
complications of Plasmodium falciparum 
malaria. 
This study also observed a significant 
(P<0.05) elevation in the levels of plasma urea 
and BUN in the Plasmodium infected patients. 
The elevated levels of plasma urea and BUN 
observed in the malaria patients are positively 
correlated to degree of parasitaemia and 
expressed irrespective of the age or sex of the 
patients. These findings are also in agreement 
with the earlier study of Nand et al. (2001) 
where raised blood urea was found in patients 
with severe falciparum malaria with an 
excellent correlation between 
hyperparasitaemia and increase in blood urea. 
The findings of this present study also agrees 
with the earlier study carried out by Onyeneke 
et al. (2003) where serum urea levels were 
found to be higher during severe parasitaemia 
with the male subjects showing significantly 
raised levels of urea (P<0.01) when compared 
with the females. The findings of this present 
study are however partly in agreement with the 
results of Ekeanyanwu and Akpoilih (2010) on 
children in Owerri, Eastern Nigeria, where it 
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was observed that the levels of serum urea, 
was significantly higher in infected children 
when compared with the respective control 
values. The relationship between malaria 
parasitaemia and serum urea was however 
negatively correlated. It also partly agrees with 
results of Ogbadoyi and Gabi (2007) in Minna, 
Nigeria and Idonije et al. (2011) where 
significant (P<0.05) elevation in blood urea 
was found in female malaria patients. Values 
generally obtained for females were found to 
be lower than that of male counterparts. This 
study also partly corroborates the findings of 
Adeosun et al. (2007) in children from South 
Western Nigeria, where plasma urea levels in 
the parasitaemic children were significantly 
elevated (P<0.001) than that in the non-
parasitaemic controls but this elevation was 
not found to increase with parasitaemia. 
The findings of elevated plasma urea 
and blood urea nitrogen (azotaemia) in this 
study can be attributed to various factors like 
dehydration, increased catabolism and 
impaired renal function. There is increased 
excretion of nitrogen and at first decreased 
elimination of phosphates in falciparum 
malaria patients. Infected erythrocytes take up 
amino acids at a greater rate than uninfected 
cells and thus there is a decrease in the 
accumulation of amino acids (Wernsdorfer and 
McGregor, 1988). Urea being the end product 
of protein metabolism and the principal form in 
which nitrogen is excreted by the body 
therefore increases due to this increase in 
amino acid/protein metabolism (Wernsdorfer 
and McGregor, 1988). During malarial attack, 
a decrease in plasma protein level has been 
observed and albumin concentration falls 
(Thurnham et al., 1983). Protein deficiency is 
very high, and this is due to the fact that there 
is excessive body protein catabolism in fever, 
one of the symptoms of malaria. Episodes of 
acute malaria infection are thought therefore to 
cause an increase in the levels of serum urea 
(Philips, 1984). 
Our results also observed a significant 
(P<0.05) elevation in plasma creatinine in 
malaria infected patients. The elevated level of 
plasma creatinine observed in the malaria 
patients, positively correlated with the degree 
of parasitaemia and is experienced 
irrespective of age or sex. These findings are 
in agreement with the earlier findings in 
Plasmodium falciparum malaria infected 
children in Owerri, Eastern Nigeria obtained by 
Ekeanyanwu and Akpoilih (2010), that of Nand 
et al. (2001) in Haryana, India and that of 
Idonije et al. (2011) in Ekpoma, Nigeria, where 
raised plasma creatinine levels were found in 
patients with severe falciparum malaria with an 
excellent positive correlation between 
hyperparasitaemia and increase in levels of 
plasma creatinine. Our results also supports 
the study earlier carried out by Onyeneke et al. 
(2003) where serum creatinine levels were 
found to increase significantly in moderate and 
severe parasitaemia when compared to the 
control, with this increase being more in the 
males when compared to the females. The 
results also is partly in agreement with earlier 
study of Adeosun et al. (2007) on children 
from South Western Nigeria, where it was 
found that plasma creatinine levels in the 
parasitaemic children were significantly 
elevated (P<0.001) than that in the non-
parasitaemic controls but this elevation was 
not found to increase with increasing 
parasitaemia. 
The elevated plasma creatinine found 
in this study could be attributed to various 
factors, like increased catabolism and 
impaired renal function (Nand et al., 2001). 
Episodes of acute malaria infection are 
thought to cause an increase in the levels of 
serum creatinine (Phillips, 1984). In Thailand, 
Philips (1984) showed that about a third of 
adult patients with cerebral malaria had 
elevated creatinine. 
The findings of this study are striking. 
The results indicate a possible impairment in 
renal function in these malaria patients. The 
azotaemia, metabolic acidosis and significantly 
elevated plasma creatinine levels observed in 
this study is enough to conclude that the 
kidneys of these malaria patients may be 
impaired. This is further confirmed by the 
hyponatraemia, significantly elevated plasma 
potassium and blood urea nitrogen levels, as 
they exist with the former as markers of 
impaired renal function. 
Considering the fact that these 
patients were not known to suffer from any 
other ailment apart from malaria (hospital 
records), it can be said that this study reveals 
that infection with Plasmodium falciparum 
parasite leads to a kind of renal impairment in 
these patients within Benin metropolis, South-
South Nigeria, which if not properly managed 
could progress to renal failure. Physicians may 
therefore be advised to perform routine kidney 
function tests for their malaria patients 
especially those whose conditions appear to 
be severe, resistant, or prolonged in terms of 
recovery time as they may be experiencing a 
complication of malaria infection in their 
kidneys! The results of such tests can lead to 
proactive interventions that will reduce 
recovery time and prevent fatal consequences. 
More study should be carried out to broaden 
the knowledge and elucidate the exact 
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pathophysiology of how malaria causes renal 
disorders in our local environment. 
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